Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  2017-03-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612822666161025145639PMID 27784238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effective interaction studies for inhibition of DNA ligase protein from Staphylococcus aureus

  2015cited by this paper
• Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.

  2015cited by this paper
• Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR development.

  2015cited by this paper
• Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.

  2014cited by this paper
• Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase.

  2014cited by this paper
• Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.

  2012cited by this paper
• Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series.

  2012cited by this paper
• Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones.

  2012cited by this paper
• Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity.

  2012cited by this paper
• Virtual screening of specific chemical compounds by exploring E.coli NAD+-dependent DNA ligase as a target for antibacterial drug discovery

  2011cited by this paper
• Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.

  2011cited by this paper
• Structure-based discovery of antibacterial drugs

  2010cited by this paper
• Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo

  2010cited by this paper
• Discovery and design of DNA and RNA ligase inhibitors in infectious microorganisms

  2009cited by this paper
• DNA Ligases: Progress and Prospects*

  2009cited by this paper
• High-throughput and in silico screenings in drug discovery

  2009cited by this paper
• NAD+‐Dependent DNA Ligase: A novel target waiting for the right inhibitor

  2008cited by this paper
• DNA and RNA ligases: structural variations and shared mechanisms.

  2008cited by this paper
• Identification and characterization of an inhibitor specific to bacterial NAD+‐dependent DNA ligases

  2008cited by this paper
• Last stop on the road to repair: structure of E. coli DNA ligase bound to nicked DNA-adenylate.

  2007cited by this paper
• NAD+‐dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: Novel structure‐function relationship and identification of a specific inhibitor

  2007cited by this paper
• DNA ligases: structure, reaction mechanism, and function.

  2006cited by this paper
• Investigation of mechanism-based thrombin inhibitors: Implications of a highly conserved water molecule for the binding of coumarins within the S pocket.

  2006cited by this paper
• High-Throughput Screening: Update on Practices and Success

  2006cited by this paper
• Antibiotics: where did we go wrong?

  2005cited by this paper
• Analysis of ligation and DNA binding by Escherichia coli DNA ligase (LigA).

  2005cited by this paper
• NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis

  2005cited by this paper
• Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I

  2005cited by this paper
• The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases.

  2004cited by this paper
• Ligand efficiency: a useful metric for lead selection.

  2004cited by this paper
• Biochemical and Genetic Analysis of the Four DNA Ligases of Mycobacteria*

  2004cited by this paper
• Fragment-based lead discovery

  2004cited by this paper
• Human DNA ligase I completely encircles and partially unwinds nicked DNA

  2004cited by this paper
• The preferential inhibition of Bacillus subtilis spore outgrowth by chloroquine

  2004cited by this paper
• Structural rearrangement accompanying NAD+ synthesis within a bacterial DNA ligase crystal.

  2004cited by this paper
• High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.

  2004cited by this paper
• Cofactor Binding Modulates the Conformational Stabilities and Unfolding Patterns of NAD+-dependent DNA Ligases from Escherichia coli and Thermus scotoductus*

  2003cited by this paper
• Specific and Potent Inhibition of NAD+-dependent DNA Ligase by Pyridochromanones*

  2003cited by this paper
• Conserved Residues in Domain Ia Are Required for the Reaction of Escherichia coli DNA Ligase with NAD+ *

  2002cited by this paper
• Development of a fluorescence resonance energy transfer assay for measuring the activity of Streptococcus pneumoniae DNA ligase, an enzyme essential for DNA replication, repair, and recombination.

  2002cited by this paper
• Integration of virtual and high-throughput screening

  2002cited by this paper
• Geno3D: automatic comparative molecular modelling of protein

  2002cited by this paper
• Novel miniaturized systems in high-throughput screening.

  2002cited by this paper
• Cloning and Functional Characterization of an NAD+-Dependent DNA Ligase from Staphylococcus aureus

  2001cited by this paper
• Bacterial DNA ligases

  2001cited by this paper
• DNA ligases in the repair and replication of DNA.

  2000cited by this paper
• The NAD-dependent ligase encoded by yerG is an essential gene of Bacillus subtilis.

  2000cited by this paper
• Crystal structure of NAD+‐dependent DNA ligase: modular architecture and functional implications

  2000cited by this paper
• Structural and mechanistic conservation in DNA ligases.

  2000cited by this paper
• Structure of the adenylation domain of an NAD+-dependent DNA ligase.

  1999cited by this paper
• Specific Inhibition of the Eubacterial DNA Ligase by Arylamino Compounds

  1999cited by this paper
• Functional domains of an NAD+-dependent DNA ligase.

  1999cited by this paper
• Mutational analysis of Chlorella virus DNA ligase: catalytic roles of domain I and motif VI.

  1998cited by this paper
• Structure-based design of potent inhibitors of scytalone dehydratase: displacement of a water molecule from the active site.

  1998cited by this paper
• Cloning of linear DNAs in vivo by overexpressed T4 DNA ligase: construction of a T4 phage hoc gene display vector.

  1997cited by this paper
• The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump

  1997cited by this paper
• X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes.

  1997cited by this paper
• New strategies for antibacterial drug design.

  1997cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Characterization of human DNA ligase I expressed in a baculovirus-insect cell system.

  1995cited by this paper
• Mammalian DNA ligases.

  1992cited by this paper
• DNA ligase and the pyridine nucleotide cycle in Salmonella typhimurium

  1989cited by this paper
• Conditional-lethal deoxyribonucleic acid ligase mutant of Escherichia coli

  1979cited by this paper
• DNA Ligase: Structure, Mechanism, and Function

  1974cited by this paper
• Mammalian deoxyribonucleic acid ligase. Isolation of an active enzyme-adenylate complex.

  1973cited by this paper

• Antibacterial Ingredients and Modes of the Methanol-Phase Extract from the Fruit of Amomum villosum Lour.

  2024cites this paper
• Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity

  2022cites this paper
• DESIGN, BINDING AFFINITY STUDIES AND IN SILICO ADMET PREDICTIONS OF NOVEL ISOXAZOLES AS POTENTIAL ANTI-BACTERIAL

  2022cites this paper
• Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial

  2021cites this paper
• Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD+-dependent DNA Ligase A.

  2020cites this paper